Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001104659-25-124513
Filing Date
2025-12-29
Accepted
2025-12-29 07:52:03
Documents
1
Effectiveness Date
2025-12-29

Document Format Files

Seq Description Document Type Size
1 15-12G tm2534191d1_1512g.htm 15-12G 11773
  Complete submission text file 0001104659-25-124513.txt   13034
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-36296 | Film No.: 251603128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)